Group 1 - The Hang Seng Index rose over 1% in the afternoon session [1] - The Hang Seng Tech Index increased by 0.29% [1]

Group 1 - Cerebras, an AI chip manufacturer, has secretly submitted an IPO application and is in discussions with potential investors, aiming for a listing as early as April, despite previous targets set for Q2 2026 [1] - The company has entered into a multi-billion dollar partnership with OpenAI to provide 750 megawatts of computing power [1] - Cerebras is negotiating to raise $1 billion, which would increase its valuation to $22 billion [1] Group 2 - The IPO process has faced challenges, initially submitting the application in September 2024, but it was stalled due to U.S. federal scrutiny over its partnership with Abu Dhabi AI company G42 [1] - In October 2025, after raising $1.1 billion and achieving a valuation of $8.1 billion, Cerebras withdrew its IPO plans [1] - The U.S. Foreign Investment Committee completed its review earlier this year, allowing Cerebras to announce in March that pending issues had been resolved [1] Group 3 - Founded in 2015 and headquartered in Sunnyvale, California, Cerebras released the WSE-3 chip and CS-3 system last year, setting new performance benchmarks in AI inference and training [1] - The company's client base includes industry leaders such as Meta Platforms and AstraZeneca [1]

声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 天眼查资料显示，云米互联科技（广东）有限公司，成立于2019年，位于佛山市，是一家以从事专业技 术服务业为主的企业。企业注册资本2000万美元。通过天眼查大数据分析，云米互联科技（广东）有限 公司共对外投资了1家企业，参与招投标项目6次，财产线索方面有商标信息2条，专利信息1314条，此 外企业还拥有行政许可18个。 国家知识产权局信息显示，云米互联科技（广东）有限公司取得一项名为"智能空调设备的自动控制方 法及装置"的专利，授权公告号CN115562093B，申请日期为2021年7月。 本文源自：市场资讯 作者：情报员 ...

Group 1 - The company, Youjia Innovation (02431.HK), announced the repurchase of 6.3442 million H shares, totaling approximately HKD 99.8013 million [1] - The average repurchase price per H share was approximately HKD 15.73 [1]

Core Viewpoint - The company, Aide New Energy (02623), has seen a significant stock price increase of nearly 15%, currently trading at 5.32 HKD, with a transaction volume of 21.78 million HKD. This surge is attributed to the announcement of a strategic investment in Horizon Minerals, marking a shift from its core titanium iron business to the promising gold mining sector [1]. Group 1: Investment Details - Aide New Energy plans to invest 39.5 million AUD in Horizon Minerals, resulting in the company holding approximately 9.95% of the issued share capital of the target company post-investment [1]. - Horizon Minerals is identified as a mid-tier gold producer in Australia, with an estimated mineral resource of 34.32 million tons, containing 1.7 grams of gold per ton, totaling approximately 1.88 million ounces of gold [1]. Group 2: Resource Potential - The key assets of Horizon Minerals are located in Western Australia, specifically in Boorara and Burbanks, which are considered to have superior resource endowments and significant development potential [1].

Core Viewpoint - China Antibody-B (03681) has received approval from the National Medical Products Administration (NMPA) for its clinical trial application (IND) for the innovative treatment product SM17, expanding its use from atopic dermatitis (AD) to inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC) [1] Group 1 - The stock price of China Antibody-B increased by over 5%, reaching 2.1 HKD with a trading volume of 9.53 million HKD [1] - The IND approval marks a significant milestone for the company, addressing a substantial unmet medical need in chronic and debilitating diseases [1] - The company has completed follow-up for the Phase I bridging study of the subcutaneous injection formulation of SM17 in healthy volunteers, with data to support the advancement of IBD indications into Phase II clinical development [1] Group 2 - In addition to advancing the IND, the company is completing a bridging study transitioning from intravenous to subcutaneous injection, expected to be finished by the first quarter of this year [1] - The company anticipates initiating Phase II clinical trials for AD in the second quarter of this year [1] - The expansion of SM17's indications from AD to IBD is viewed as a significant opportunity to address unmet medical needs in a clinically and commercially valuable area [1]

Group 1 - The court has lifted the unilateral injunction issued on January 11, 2026, allowing the company to operate without the previous restrictions [1] - The court's ruling includes a new hearing date set for February 16, 2026, with a judgment to be announced on February 18, 2026 [1] - The company is no longer restricted from issuing new shares, appointing placement agents for new share placements, registering new shareholders, or applying for the listing of new shares on the stock exchange [1] Group 2 - The company is seeking legal advice regarding the judgment and plans to pursue the plaintiff for legal costs incurred in responding to the summons [2] - The company reserves the right to claim damages from the plaintiff for any false or misleading statements made in the affidavit submitted to the court, as well as for losses incurred due to the now-lifted unilateral injunction [2]

Core Viewpoint - The company, Esprit Holdings Limited (00330.HK), expects to report an unaudited consolidated loss attributable to shareholders of approximately HKD 7 million for the fiscal year ending December 31, 2025, a significant reduction compared to a loss of approximately HKD 1.227 billion for the same period in 2024 [1] Group 1 - The anticipated loss reduction is primarily due to a substantial decrease in operating expenses from continuing operations [1] - The company has also benefited from non-recurring termination merger gains resulting from its restructuring plan [1]

Group 1 - The core viewpoint of the articles highlights a positive outlook for the restaurant sector in China, with expected sales growth accelerating to 4.2% year-on-year by 2026, up from 3.2% last year [1] - Goldman Sachs notes that while overall consumer spending has not shown significant improvement, restaurant demand has stabilized over the past few months, with price increases observed to cope with rising operational and raw material costs [1] - Citigroup's channel checks indicate that Haidilao's table turnover rate during the 2026 Spring Festival has increased by over 5% year-on-year, with expectations of positive growth in table turnover for January and February [1] Group 2 - Guojin Securities points out that the extended Spring Festival holiday and ongoing policy support have stimulated positive data in restaurant and travel sectors, leading to increased demand for consumer goods [2] - The report suggests that cautious inventory levels among distributors prior to the holiday will likely lead to a replenishment cycle in late February to March, supported by a low base from the previous year's Q1 [2] - The restaurant and snack demand during the Spring Festival is expected to drive post-holiday inventory replenishment actions, with many companies likely to report improvements in their Q1 results [2]

国家知识产权局信息显示，波音公司取得一项名为"增材制造系统和方法"的专利，授权公告号 CN113523309B，申请日期为2021年4月。 作者：情报员 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 本文源自：市场资讯 ...